Annual EBITDA
$19.24B$71.00M-0.37%
Summary
- Current Value
- As of today, BMY annual EBITDA is $19.24B, down -0.37% on
- Historical Performance
- BMY annual EBITDA is down -1.64% over the past 3 years, up +28.44% over the past 5 years
- All-Time High Comparison
- BMY annual EBITDA is currently -5.23% below its historical high of $20.30B set on
- 3-Year Low Comparison
- BMY annual EBITDA is +5.22% above its 3-year low of $18.28B reached on
- Sector Comparison
- BMY annual EBITDA is higher than 99.20% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $19.24B | -0.4% | -1.6% | +28.4% | +179.6% | |
| Quarterly EBITDA | $5.05B | +3.7% | +10.9% | +12.8% | +157.3% | |
| TTM EBITDA | $19.38B | +2.2% | +2.7% | +13.5% | +162.2% | |
| Price | $61.35 | +30.4% | +20.7% | +3.9% | +99.1% | |
| PE Ratio | 13.59 | -14.5% | +5.4% | – | -14.3% | |
| Annual Revenue | $48.19B | -0.2% | +4.4% | +13.3% | +147.3% | |
| Annual EPS | $3.46 | +178.4% | +17.3% | +186.7% | +93.3% | |
| Annual EBIT | $14.99B | +55.2% | +61.7% | +233.7% | +144.3% | |
| Annual Net Income | $7.06B | +179.0% | +11.2% | +178.4% | +56.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $19.56B | N/A | -1.6% |
| 5Y | $20.30B | -5.2% | |
| All | $20.30B | -5.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $18.28B | +5.2% | |
| 5Y | $14.98B | N/A | +28.4% |
| All | $508.00M | +3687.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of BMY?
- As of today, BMY annual EBITDA is $19.24B
- What is 1-year change in BMY annual EBITDA?
- BMY annual EBITDA is down -0.37% year-over-year
- What is 3-year change in BMY annual EBITDA?
- BMY annual EBITDA is down -1.64% over the past 3 years
- How far is BMY annual EBITDA from its all-time high?
- BMY annual EBITDA is currently -5.23% below its historical high of $20.30B set on December 31, 2021
- How does BMY annual EBITDA rank versus sector peers?
- BMY annual EBITDA is higher than 99.20% of companies in Healthcare sector
- When is BMY next annual earnings release?
- The next annual earnings release for BMY is on
EBITDA Formula
Quarterly EBITDA
$5.05B$238.00M-4.50%
Summary
- Current Value
- As of today, BMY quarterly EBITDA is $5.05B, down -4.50% on
- Historical Performance
- BMY quarterly EBITDA is up +3.70% year-over-year, up +10.89% over the past 3 years
- All-Time High Comparison
- BMY quarterly EBITDA is currently -5.69% below its historical high of $5.36B set on
- 3-Year Low Comparison
- BMY quarterly EBITDA is +23.50% above its 3-year low of $4.09B reached on
- Sector Comparison
- BMY quarterly EBITDA is higher than 99.03% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $5.05B | -4.5% | +3.7% | +10.9% | +12.8% | |
| Annual EBITDA | $19.24B | – | -0.4% | -1.6% | +28.4% | |
| TTM EBITDA | $19.38B | +0.9% | +2.2% | +2.7% | +13.5% | |
| Price | $61.35 | -7.1% | +30.4% | +20.7% | +3.9% | |
| PE Ratio | 13.59 | -6.6% | -14.5% | +5.4% | – | |
| Quarterly Revenue | $13.08B | +0.7% | +7.0% | +19.2% | +12.5% | |
| Quarterly EPS | $1.05 | -35.0% | -2.4% | +12.7% | +52.8% | |
| Quarterly EBIT | $4.41B | -5.8% | +14.7% | +109.5% | +154.6% | |
| Quarterly Net Income | $2.16B | -34.8% | -1.5% | +11.8% | +39.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.29B | -4.5% | |
| 3Y | $5.29B | -4.5% | |
| 5Y | $5.36B | -5.7% | |
| All | $5.36B | -5.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.37B | +15.5% | |
| 3Y | $4.09B | +23.5% | |
| 5Y | $4.09B | +23.5% | |
| All | -$5.75B | +187.9% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of BMY?
- As of today, BMY quarterly EBITDA is $5.05B
- What is BMY quarterly EBITDA most recent change?
- BMY quarterly EBITDA was down -4.50% on September 30, 2026
- What is 1-year change in BMY quarterly EBITDA?
- BMY quarterly EBITDA is up +3.70% year-over-year
- How far is BMY quarterly EBITDA from its all-time high?
- BMY quarterly EBITDA is currently -5.69% below its historical high of $5.36B set on March 31, 2022
- How does BMY quarterly EBITDA rank versus sector peers?
- BMY quarterly EBITDA is higher than 99.03% of companies in Healthcare sector
- When is BMY next earnings release?
- The next earnings release for BMY is on
EBITDA Formula
TTM EBITDA
$19.38B$180.00M+0.94%
Summary
- Current Value
- As of today, BMY TTM EBITDA is $19.38B, up +0.94% on
- Historical Performance
- BMY TTM EBITDA is up +2.16% year-over-year, up +2.66% over the past 3 years
- All-Time High Comparison
- BMY TTM EBITDA is currently -3.60% below its historical high of $20.10B set on
- 3-Year Low Comparison
- BMY TTM EBITDA is +11.01% above its 3-year low of $17.45B reached on
- Sector Comparison
- BMY TTM EBITDA is higher than 99.03% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $19.38B | +0.9% | +2.2% | +2.7% | +13.5% | |
| Annual EBITDA | $19.24B | – | -0.4% | -1.6% | +28.4% | |
| Quarterly EBITDA | $5.05B | -4.5% | +3.7% | +10.9% | +12.8% | |
| Price | $61.35 | -7.1% | +30.4% | +20.7% | +3.9% | |
| PE Ratio | 13.59 | -6.6% | -14.5% | +5.4% | – | |
| TTM Revenue | $50.05B | +1.7% | +4.2% | +11.4% | +10.1% | |
| TTM EPS | $4.51 | -0.6% | +52.4% | +14.5% | +287.9% | |
| TTM EBIT | $16.48B | +3.5% | +17.6% | +82.5% | +165.1% | |
| TTM Net Income | $9.24B | -0.4% | +52.9% | +11.3% | +271.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $19.38B | at high | |
| 3Y | $19.38B | at high | |
| 5Y | $20.10B | -3.6% | |
| All | $20.10B | -3.6% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $18.97B | N/A | +2.2% |
| 3Y | $17.45B | +11.0% | |
| 5Y | $17.08B | N/A | +13.5% |
| All | -$3.65B | +631.3% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of BMY?
- As of today, BMY TTM EBITDA is $19.38B
- What is BMY TTM EBITDA most recent change?
- BMY TTM EBITDA was up +0.94% on September 30, 2026
- What is 1-year change in BMY TTM EBITDA?
- BMY TTM EBITDA is up +2.16% year-over-year
- How far is BMY TTM EBITDA from its all-time high?
- BMY TTM EBITDA is currently -3.60% below its historical high of $20.10B set on December 31, 2022
- How does BMY TTM EBITDA rank versus sector peers?
- BMY TTM EBITDA is higher than 99.03% of companies in Healthcare sector
- When is BMY next earnings release?
- The next earnings release for BMY is on
EBITDA Formula
Data Sources & References
- BMY Official Website www.bms.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- BMY Profile on Yahoo Finance finance.yahoo.com/quote/BMY
- BMY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bmy
